1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Test Type Outlook
3.4. End User Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of influenza and increasing number of influenza screening test
5.1.1.2. Growth in research funding for influenza diagnostics
5.1.1.3. Growing awareness for early detection faster diagnosis using specific diagnostic tests
5.1.2. Restraints
5.1.2.1. Stringent regulatory framework for the approval of new diagnostic tests
5.1.3. Opportunities
5.1.3.1. Development of advanced diagnosis test such as CLIA-waived POC molecular influenza tests
5.1.3.2. Availability of strong distribution network
5.1.4. Challenges
5.1.4.1. Rising healthcare costs
5.2. Cumulative Impact of COVID-19
5.3. Porters Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry

6. Influenza Diagnostic Market, by Test Type
6.1. Introduction
6.2. Cell Culture
6.3. Rapid Influenza Diagnostic Tests
6.4. Reverse Transcription-Polymerase Chain Reaction (RT-PCR)

7. Influenza Diagnostic Market, by End User
7.1. Introduction
7.2. Hospitals
7.3. Laboratories
7.4. Point-of-Care Testing

8. Americas Influenza Diagnostic Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
8.6.1. California
8.6.2. Florida
8.6.3. Illinois
8.6.4. New York
8.6.5. Ohio
8.6.6. Pennsylvania
8.6.7. Texas

9. Asia-Pacific Influenza Diagnostic Market
9.1. Introduction
9.2. China
9.3. India
9.4. Indonesia
9.5. Japan
9.6. Malaysia
9.7. Philippines
9.8. South Korea
9.9. Thailand

10. Europe, Middle East & Africa Influenza Diagnostic Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Alere Inc.
12.3. BD Medical
12.4. DiaSorin
12.5. Luminex Corporation
12.6. Quidel Corporation
12.7. Roche Diagnostics
12.8. SA Scientific
12.9. Sekisui Diagnostics
12.10. Thermo Fisher Scientific

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
13.3. Contact Details

List of Figures

FIGURE 1. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 4. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 5. GLOBAL INFLUENZA DIAGNOSTIC MARKET: MARKET DYNAMICS
FIGURE 6. GLOBAL INFLUENZA DIAGNOSTIC MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 7. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (%)
FIGURE 8. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2026
FIGURE 10. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY CELL CULTURE, 2018-2026 (USD MILLION)
FIGURE 11. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY CELL CULTURE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 12. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY RAPID INFLUENZA DIAGNOSTIC TESTS, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY RAPID INFLUENZA DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION (RT-PCR), 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION (RT-PCR), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 17. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2026
FIGURE 19. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 25. AMERICAS INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 26. AMERICAS INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 28. ARGENTINA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 29. BRAZIL INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 30. CANADA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 31. MEXICO INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 33. CALIFORNIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 34. FLORIDA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 35. ILLINOIS INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 36. NEW YORK INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 37. OHIO INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 38. PENNSYLVANIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 39. TEXAS INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 40. ASIA-PACIFIC INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 41. ASIA-PACIFIC INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 43. CHINA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 44. INDIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 45. INDONESIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 46. JAPAN INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 47. MALAYSIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 48. PHILIPPINES INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 49. SOUTH KOREA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 50. THAILAND INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 54. FRANCE INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 55. GERMANY INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. ITALY INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. NETHERLANDS INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 58. QATAR INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 59. RUSSIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 60. SAUDI ARABIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 61. SOUTH AFRICA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 62. SPAIN INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 63. UNITED ARAB EMIRATES INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. UNITED KINGDOM INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. GLOBAL INFLUENZA DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL INFLUENZA DIAGNOSTIC MARKET: MARKET SHARE ANALYSIS, BY QUADRANT
FIGURE 67. GLOBAL INFLUENZA DIAGNOSTIC MARKET: MARKET SHARE ANALYSIS, BY COMPANY
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INFLUENZA DIAGNOSTIC MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL INFLUENZA DIAGNOSTIC MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY CELL CULTURE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY RAPID INFLUENZA DIAGNOSTIC TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION (RT-PCR), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL INFLUENZA DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. ARGENTINA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ARGENTINA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. BRAZIL INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. BRAZIL INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CANADA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CANADA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. MEXICO INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. MEXICO INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. UNITED STATES INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. UNITED STATES INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CALIFORNIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CALIFORNIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. FLORIDA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. FLORIDA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ILLINOIS INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ILLINOIS INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. NEW YORK INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. NEW YORK INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. OHIO INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. OHIO INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. PENNSYLVANIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. PENNSYLVANIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. TEXAS INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. TEXAS INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ASIA-PACIFIC INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ASIA-PACIFIC INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CHINA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. INDIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. INDIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDONESIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDONESIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. JAPAN INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. JAPAN INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. MALAYSIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. MALAYSIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. PHILIPPINES INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. PHILIPPINES INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. SOUTH KOREA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. SOUTH KOREA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. THAILAND INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. THAILAND INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA INFLUENZA DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. FRANCE INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. FRANCE INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. GERMANY INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. GERMANY INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. ITALY INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. ITALY INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. NETHERLANDS INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. NETHERLANDS INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. QATAR INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. QATAR INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. RUSSIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. RUSSIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. SAUDI ARABIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. SAUDI ARABIA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. SOUTH AFRICA INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. SOUTH AFRICA INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. SPAIN INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. SPAIN INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. UNITED ARAB EMIRATES INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. UNITED ARAB EMIRATES INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. UNITED KINGDOM INFLUENZA DIAGNOSTIC MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. UNITED KINGDOM INFLUENZA DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. GLOBAL INFLUENZA DIAGNOSTIC MARKET: SCORES
TABLE 84. GLOBAL INFLUENZA DIAGNOSTIC MARKET: BUSINESS STRATEGY
TABLE 85. GLOBAL INFLUENZA DIAGNOSTIC MARKET: PRODUCT SATISFACTION
TABLE 86. GLOBAL INFLUENZA DIAGNOSTIC MARKET: RANKING
TABLE 87. GLOBAL INFLUENZA DIAGNOSTIC MARKET: MERGER & ACQUISITION
TABLE 88. GLOBAL INFLUENZA DIAGNOSTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 89. GLOBAL INFLUENZA DIAGNOSTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 90. GLOBAL INFLUENZA DIAGNOSTIC MARKET: INVESTMENT & FUNDING
TABLE 91. GLOBAL INFLUENZA DIAGNOSTIC MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 92. GLOBAL INFLUENZA DIAGNOSTIC MARKET: LICENSE & PRICING
TABLE 93. GLOBAL INFLUENZA DIAGNOSTIC MARKET: CONTACT DETAILS

Companies Mentioned

Abbott Laboratories
Alere Inc.
BD Medical
DiaSorin
Luminex Corporation
Quidel Corporation
Roche Diagnostics
SA Scientific
Sekisui Diagnostics
Thermo Fisher Scientific